Clarius Group LLC’s Merck MRK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q4 | $2.43M | Sell |
23,078
-2,320
| -9% | -$218K | 0.14% | 63 |
|
|
2025
Q3 | $2.13M | Buy |
25,398
+2,887
| +13% | +$238K | 0.13% | 69 |
|
|
2025
Q2 | $1.78M | Buy |
22,511
+1,420
| +7% | +$113K | 0.1% | 93 |
|
|
2025
Q1 | $1.89M | Sell |
21,091
-2,941
| -12% | -$275K | 0.12% | 76 |
|
|
2024
Q4 | $2.39M | Buy |
24,032
+171
| +0.7% | +$17.6K | 0.16% | 60 |
|
|
2024
Q3 | $2.73M | Sell |
23,861
-1,085
| -4% | -$129K | 0.19% | 54 |
|
|
2024
Q2 | $3.09M | Sell |
24,946
-827
| -3% | -$107K | 0.22% | 48 |
|
|
2024
Q1 | $3.4M | Sell |
25,773
-3,489
| -12% | -$430K | 0.23% | 49 |
|
|
2023
Q4 | $3.19M | Buy |
29,262
+7,608
| +35% | +$790K | 0.26% | 53 |
|
|
2023
Q3 | $2.23M | Sell |
21,654
-6,154
| -22% | -$663K | 0.21% | 60 |
|
|
2023
Q2 | $3.21M | Buy |
27,808
+1,832
| +7% | +$208K | 0.25% | 49 |
|
|
2023
Q1 | $2.76M | Sell |
25,976
-81
| -0.3% | -$8.74K | 0.23% | 56 |
|
|
2022
Q4 | $2.89M | Buy |
26,057
+406
| +2% | +$41.5K | 0.26% | 55 |
|
|
2022
Q3 | $2.21M | Buy |
25,651
+1,956
| +8% | +$175K | 0.22% | 59 |
|
|
2022
Q2 | $2.16M | Buy |
23,695
+2,707
| +13% | +$240K | 0.22% | 62 |
|
|
2022
Q1 | $1.61M | Hold |
20,988
| – | – | 0.13% | 92 |
|
|
2021
Q4 | $1.61M | Buy |
20,988
+768
| +4% | +$61.2K | 0.13% | 92 |
|
|
2021
Q3 | $1.52M | Sell |
20,220
-156
| -0.8% | -$11.9K | 0.14% | 88 |
|
|
2021
Q2 | $1.58M | Sell |
20,376
-1,112
| -5% | -$82.7K | 0.14% | 86 |
|
|
2021
Q1 | $1.58M | Sell |
21,488
-2,760
| -11% | -$204K | 0.15% | 77 |
|
|
2020
Q4 | $1.89M | Buy |
24,248
+1,394
| +6% | +$107K | 0.2% | 53 |
|
|
2020
Q3 | $1.81M | Sell |
22,854
-1,681
| -7% | -$132K | 0.23% | 48 |
|
|
2020
Q2 | $1.81M | Buy |
24,535
+2,728
| +13% | +$205K | 0.25% | 47 |
|
|
2020
Q1 | $1.6M | Buy |
21,807
+327
| +2% | +$25.7K | 0.3% | 45 |
|
|
2019
Q4 | $1.88M | Sell |
21,480
-2,141
| -9% | -$176K | 0.3% | 48 |
|
|
2019
Q3 | $1.9M | Buy |
23,621
+4,806
| +26% | +$385K | 0.35% | 45 |
|
|
2019
Q2 | $1.5M | Buy |
18,815
+2,329
| +14% | +$178K | 0.3% | 48 |
|
|
2019
Q1 | $1.31M | Buy |
16,486
+8,726
| +112% | +$653K | 0.32% | 49 |
|
|
2018
Q4 | $566K | Buy |
7,760
+1,702
| +28% | +$120K | 0.21% | 58 |
|
|
2018
Q3 | $410K | Buy |
+6,058
| New | +$386K | 0.15% | 68 |
|
|
2017
Q3 | – | Sell |
-6,225
| Closed | -$381K | – | 88 |
|
|
2017
Q2 | $381K | Hold |
6,225
| – | – | 0.16% | 61 |
|
|
2017
Q1 | $378K | Buy |
6,225
+140
| +2% | +$8.49K | 0.16% | 60 |
|
|
2016
Q4 | $342K | Buy |
6,085
+43
| +0.7% | +$2.52K | 0.14% | 62 |
|
|
2016
Q3 | $362K | Sell |
6,042
-1,774
| -23% | -$104K | 0.17% | 58 |
|
|
2016
Q2 | $429K | Sell |
7,816
-629
| -7% | -$33.5K | 0.23% | 53 |
|
|
2016
Q1 | $426K | Buy |
8,445
+3,141
| +59% | +$154K | 0.24% | 50 |
|
|
2015
Q4 | $267K | Buy |
+5,304
| New | +$267K | 0.15% | 58 |
|
Other funds holding MRK
Clarius Group LLC's MRK Position: Q4 2025 in Review
Clarius Group LLC reduced its Merck (MRK) stake by 9.1% in Q4 2025, selling an estimated $218K and leaving 23,078 shares worth $2.43M. The position accounts for 0.14% of the portfolio, ranked #63.
Clarius Group LLC first reported a position in MRK in Q4 2015 and has held it in 37 quarters since. The position peaked at $3.4M in Q1 2024. 3,652 funds tracked by Wall St. Rank hold MRK as of Q4 2025.
- Clarius Group LLC held 23,078 shares of Merck worth $2.43M as of Q4 2025.
- Clarius Group LLC sold 2,320 Merck shares in Q4 2025, an estimated $218K.
- Merck made up 0.14% of Clarius Group LLC's portfolio in Q4 2025, its #63 holding.
- Clarius Group LLC first reported a position in Merck in Q4 2015 and has held it in 37 quarters since.
- Clarius Group LLC's Merck position peaked at $3.4M in Q1 2024.
- 3,652 funds tracked by Wall St. Rank held Merck as of Q4 2025.
Based on Clarius Group LLC's 13F filing for Q4 2025, filed 14 Jan 2026.